Beyond conventional therapies: the evolution of targeted agents and immunotherapies in triple-negative breast cancer

ACTA PHARMACOLOGICA SINICA · Published 2026-08-04 · DOI 10.1038/s41401-026-01892-9

Free full text

Authors (7)

Hui-fang Cheng, Yan-mei Chen, Pei-yan Liu, Xin Jin, Yi Qu, Bo Liu, Ai-zhuo Li

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Cheng, H., Chen, Y., Liu, P., et al. (2026). Beyond conventional therapies: the evolution of targeted agents and immunotherapies in triple-negative breast cancer. ACTA PHARMACOLOGICA SINICA. https://doi.org/10.1038/s41401-026-01892-9

Related articles

• Emerging Therapeutics for Patients with Triple-Negative Breast Cancer · Current Oncology Reports · 2021 · Cites or is cited by this article
• Adenosine receptor signaling in vascular diseases: from molecular mechanisms to targeted therapeutics · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Macrophage FOLR2 drives liver fibrosis via intercellular engagement of TGFβRII · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Cardiomyocyte OTUD7b drives diabetic cardiomyopathy via deubiquitinating and stabilizing TAK1 · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Astrocytic adrenergic α2 receptor contributes to the mechanisms underlying the circadian rhythmicity of seizure susceptibility · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• The solute carrier transporter SLCO5A1 as a novel therapeutic target for the treatment of myocardial infarction-induced heart failure · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Serum/glucocorticoid-regulated kinase 1 regulates vascular inflammation in atherosclerosis · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• METTL3 loss exacerbates colitis via m6A-dependent Slc39a8 regulation and epithelial lineage depletion · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Secreted chimeric proteins as a strategy to correct SOX17 deficiency and attenuate the malignant phenotype of cholangiocarcinoma cells: a proof-of-concept study · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Activation of peripheral muscarinic receptors rescues depressive-like behaviors via gut-brain-axis, involving parasympathetic excitation · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal